LUPIN HEALTHCARE (UK) LIMITED — Emtricitabine Importer Profile
Pharmaceutical Importer · #5 buyer for Emtricitabine · $100.0K import value · 2 shipments · UNITED KINGDOM · DGFT Verified
LUPIN HEALTHCARE (UK) LIMITED is the #5 importer of Emtricitabine from India with $100.0K in import value and 2 verified shipments. LUPIN HEALTHCARE (UK) LIMITED holds a 0.1% market share in Emtricitabine imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 2 formulations shipped to 1 country.
LUPIN HEALTHCARE (UK) LIMITED — Emtricitabine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Emtricitabine to LUPIN HEALTHCARE (UK) LIMITED?
Verified from 2 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LUPIN LIMITED | $100.0K | 2 | 100.0% |
LUPIN HEALTHCARE (UK) LIMITED sources Emtricitabine from 1 verified Indian supplier based on 2 customs records. The primary supplier is LUPIN LIMITED accounting for 100.0% of imports.
How Does LUPIN HEALTHCARE (UK) LIMITED Compare to Nearest Emtricitabine Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS SA | SOUTH AFRICA | $900.0K | 18 | $50.0K |
| 13 | SYNOPTIS INDUSTRIAL SP .ZO.O | POLAND | $900.0K | 18 | $50.0K |
| 5 | LUPIN HEALTHCARE (UK) LIMITED ★ | UNITED KINGDOM | $850.0K | 17 | $50.0K |
| 7 | AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $750.0K | 15 | $50.0K |
| 1 | VIATRIS HEALTHCARE (PTY) LTD, | SOUTH AFRICA | $600.0K | 12 | $50.0K |
LUPIN HEALTHCARE (UK) LIMITED ranks #5 among 493 Emtricitabine importers from India. Average shipment value of $50.0K compared to the market average of $25.7K. The closest competitors by value are MACLEODS PHARMACEUTICALS SA and SYNOPTIS INDUSTRIAL SP .ZO.O.
Where Does LUPIN HEALTHCARE (UK) LIMITED Import Emtricitabine To?
Destination countries from 2 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $100.0K | 2 | 100.0% |
LUPIN HEALTHCARE (UK) LIMITED imports Emtricitabine to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $100.0K.
What Emtricitabine Formulations Does LUPIN HEALTHCARE (UK) LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| EMTRICITABINE 200MG+TENOFOVIR DISOPROXILAS PHOSPHATE 245MG TABLETS-1BTLx30TABSOTHER-MEDICINE PUT UP FOR RETAIL SALE | $50.0K | 1 |
| EMTR TENO DIS PH 200MG 245MG TABLETS UK EMTRICITABINE 200MG TENOFOVIR DISOPROXIL AS PHOSPHATE 245MG 1BTLx30 TABS | $50.0K | 1 |
LUPIN HEALTHCARE (UK) LIMITED imports 2 distinct Emtricitabine formulations from India. The top formulation is EMTRICITABINE 200MG+TENOFOVIR DISOPROXILAS PHOSPHATE 245MG T with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Emtricitabine into United Kingdom
What LUPIN HEALTHCARE (UK) LIMITED and other importers must comply with to import Emtricitabine from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Emtricitabine
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Emtricitabine from India and How Much Does LUPIN HEALTHCARE (UK) LIMITED Import?
India exported $12.7M worth of Emtricitabine through 2,194 shipments from 141 suppliers to 117 countries, serving 493 buyers globally. LUPIN HEALTHCARE (UK) LIMITED imports $100.0K of this total, accounting for 0.1% of India's Emtricitabine exports with 2 shipments from UNITED KINGDOM. This is verified from 2 customs shipment records covering 2 distinct formulations.
What Is the Average Order Value for LUPIN HEALTHCARE (UK) LIMITED's Emtricitabine Imports?
LUPIN HEALTHCARE (UK) LIMITED's average Emtricitabine order value is $50.0K per consignment, based on 2 shipments totaling $100.0K. LUPIN HEALTHCARE (UK) LIMITED is based in UNITED KINGDOM and ranks #5 among all Emtricitabine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Emtricitabine to LUPIN HEALTHCARE (UK) LIMITED?
LUPIN HEALTHCARE (UK) LIMITED sources Emtricitabine from 1 verified Indian supplier: LUPIN LIMITED ($100.0K, 100.0%). This is based on 2 customs records.
How Does LUPIN HEALTHCARE (UK) LIMITED Compare to Other Emtricitabine Importers?
LUPIN HEALTHCARE (UK) LIMITED ranks #5 among 493 Emtricitabine importers from India with a 0.1% market share. The top 3 importers are APL SWIFT SERVICES (MALTA) LTD., ($1.9M), SYNOPTIS INDUSTRIAL SP ,ZO,O ($1.9M), NORTHSTAR DISTRIBUTION CENTER 8912 ($1.7M). LUPIN HEALTHCARE (UK) LIMITED processed 2 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Emtricitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Emtricitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: LUPIN HEALTHCARE (UK) LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as LUPIN HEALTHCARE (UK) LIMITED's capped import value divided by total capped export value for Emtricitabine across all Indian exporters.
- 5.Verified Records: This page is backed by 2 individual customs records matching LUPIN HEALTHCARE (UK) LIMITED importing Emtricitabine, covering 2 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 493+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Emtricitabine Import Data for LUPIN HEALTHCARE (UK) LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for LUPIN HEALTHCARE (UK) LIMITED's Emtricitabine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
LUPIN HEALTHCARE (UK) LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
LUPIN HEALTHCARE (UK) LIMITED × Emtricitabine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for LUPIN HEALTHCARE (UK) LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Emtricitabine. For current order-level data, contact TransData Nexus.